Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mangoceuticals (MGRX) Return on Assets (2023 - 2025)

Mangoceuticals (MGRX) has disclosed Return on Assets for 3 consecutive years, with 1.27% as the latest value for Q4 2025.

  • Quarterly Return on Assets fell 69.0% to 1.27% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 1.27% through Dec 2025, down 69.0% year-over-year, with the annual reading at 1.31% for FY2025, 25.0% down from the prior year.
  • Return on Assets hit 1.27% in Q4 2025 for Mangoceuticals, down from 1.06% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.58% in Q4 2024 to a low of 13.34% in Q1 2024.
  • Historically, Return on Assets has averaged 2.92% across 3 years, with a median of 1.06% in 2025.
  • Biggest YoY gain for Return on Assets was 1274bps in 2025; the steepest drop was -69bps in 2025.
  • Year by year, Return on Assets stood at 6.96% in 2023, then soared by 92bps to 0.58% in 2024, then crashed by -119bps to 1.27% in 2025.
  • Business Quant data shows Return on Assets for MGRX at 1.27% in Q4 2025, 1.06% in Q3 2025, and 0.67% in Q2 2025.